Controlled release injectable ondansetron formulations
US-2026027086-A1 · Jan 29, 2026 · US
Shilpa Medicare Ltd holds 95 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 95 |
| Recent patents | 12 |
| First publication | Feb 26, 2015 |
| Latest publication | Jan 29, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2026027086-A1 · Jan 29, 2026 · US
US-12521405-B2 · Jan 13, 2026 · US
US-12508247-B2 · Dec 30, 2025 · US
US-2025275925-A1 · Sep 4, 2025 · US
US-12403149-B2 · Sep 2, 2025 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2026027086-A1 · Jan 29, 2026 · US
US-12521405-B2 · Jan 13, 2026 · US
US-12508247-B2 · Dec 30, 2025 · US
US-2025275925-A1 · Sep 4, 2025 · US
US-12403149-B2 · Sep 2, 2025 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| C07B2200/13 | 20 |
| A61K47/26 | 19 |
| A61K47/10 | 19 |
| A61K9/0019 | 16 |
| A61K47/02 | 14 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 69 |
| Chemistry & Metallurgy | 46 |
| Cross-Sectional Technologies | 1 |
Answers are generated from the same data shown on this page.